Monitor for any future conversion of this 13G to a 13D, which would signal activist intent. The passive nature and prior filings suggest no near-term catalyst from this holder.
Price Chart
Executive Summary
Empery Asset Management, LP filed a Schedule 13G disclosing a passive 8.73% stake in Outlook Therapeutics, Inc., representing 21,247,856 shares of common stock as of September 30, 2026. This is an amendment to prior 13G filings, indicating a continued passive position with no intent to influence management.
Key Financial Metrics
Key Facts
- Empery Asset Management, LP disclosed beneficial ownership of 21,247,856 shares of Outlook Therapeutics common stock.
- The stake represents 8.73% of shares outstanding, based on 243,447,554 shares outstanding as of August 14, 2026.
- Filing is a Schedule 13G (passive investor), with certification that shares were not acquired to change or influence control.
- Ryan M. Lane is also listed as a reporting person, deemed to share voting and dispositive power over the same shares.
- This is an amendment to prior 13G filings (dated August 19, 2026 and April 24, 2026), tracking stake progression.
Financial Impact
8.73% passive stake valued at approximately $21.2 million based on 21,247,856 shares; no transaction details provided.
Risk Factors
- Empery Asset Management could increase or decrease position without public disclosure until next threshold crossing.
- Passive 13G filing limits immediate market impact; no control or governance changes expected.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000919574-26-006871 |
| Document: 0000919574-26-006871-index-headers.html | 0000919574-26-006871 |
| Document: 0000919574-26-006871-index.html | 0000919574-26-006871 |
| Document: 0000919574-26-006871.txt | 0000919574-26-006871 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | SC 13G | $0.5638 $0.5200 | ▼ −7.77% | ▼ −6.62% | $0.5300 (−6.00%) |
Oct 6, 2026 21d ago | Press Release | $0.5720 $0.5638 | ▼ −1.43% | ▼ −1.29% | $0.5300 (−7.34%) |
Sep 18, 2026 5w ago | 8-K | $0.6863 $0.6211 | ▼ −9.50% | ▼ −8.48% | $0.5300 (−22.77%) |
Aug 14, 2026 10w ago | 8-K | $0.7564 $0.6472 | ▲ +14.44% | ▲ +13.07% | $0.5300 (+29.93%) |
Aug 14, 2026 10w ago | 424B5 | $0.7564 $0.6472 | ▲ +14.44% | ▲ +13.07% | $0.5300 (+29.93%) |
Aug 14, 2026 10w ago | 8-K | $0.7564 $0.6472 | ▲ +14.44% | ▲ +13.07% | $0.5300 (+29.93%) |
Aug 14, 2026 10w ago | Press Release | $0.7564 $0.6472 | ▼ −14.44% | ▼ −13.07% | $0.5300 (−29.93%) |
Aug 12, 2026 10w ago | Press Release | $0.8888 $0.6763 | ▲ +23.91% | ▲ +21.94% | $0.5300 (+40.37%) |
Aug 12, 2026 10w ago | 8-K | $0.8888 $0.6763 | ▲ +23.91% | ▲ +21.94% | $0.5300 (+40.37%) |
Jul 24, 2026 13w ago | 8-K | $1.07 $0.9766 | ▼ −8.30% | ▼ −9.37% | $0.5300 (−50.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers